About this trial
Background and Purpose:
Lung resection surgery is the standard treatment for early-stage lung adenocarcinoma, but it often leads to reduced lung volume and postoperative pain, which can hinder pulmonary recovery. While standard rehabilitation includes breathing exercises (incentive spirometry) and pain management, additional strategies are needed to enhance recovery. Acupuncture has shown benefits in managing respiratory diseases like COPD and reducing surgical pain, but its specific effectiveness in rehabilitation after lung resection has not yet been established. This study aims to evaluate whether adding acupuncture to standard postoperative care can further improve lung function and recovery.
Study Design and Methods:
This is a randomized controlled clinical trial. Participants who have undergone lung resection will be assigned to one of two groups:
Control Group: Receives standard rehabilitation (lung volume training with incentive spirometry).
Intervention Group: Receives standard rehabilitation plus acupuncture therapy.
Evaluation:
One week after surgery, researchers will perform pulmonary function tests on all participants. The study will compare the two groups primarily based on improvements in lung function. Secondary outcomes, including pain levels and quality of life, will also be assessed to determine the overall benefit and safety of integrating acupuncture into postoperative recovery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
History of prior lung resection.
Trial design
Single group
Treatments tested in this trial
Acupuncture Therapy
Procedure/SurgeryAcupuncture will be administered by certified practitioners.
Incentive Spirometry (Standard Rehabilitation)
DevicePostoperative lung volume training using an incentive spirometer. Participants are instructed to perform deep breathing exercises multiple times a day as per current clinical guidelines for lung resection recovery.
Treatment groups
Trial outcomes
Primary outcomes
Change from Baseline in Forced Vital Capacity (FVC)
The change in Forced Vital Capacity (FVC), measured in liters, from the preoperative baseline to 1 week after surgery.
Change from Baseline in Forced Expiratory Volume in 1 second (FEV1)
The change in FEV1, measured in liters, from the preoperative baseline to 1 week after surgery.
Change from Baseline in Diffusing Capacity of the Lungs for Carbon Monoxide (DLCo)
The change in DLCo (measured in mL/min/mmHg) from the preoperative baseline to 1 week after surgery, to assess the gas exchange efficiency of the lungs.
Secondary outcomes
Postoperative Dyspnea Severity (Borg Scale)
Assessed using the Modified Borg Scale to evaluate the severity of shortness of breath. The scale ranges from 0 (no breathlessness at all) to 10 (maximal breathlessness).
Postoperative Pain Intensity (Numerical Rating Scale, NRS)
Assessed using the Numerical Rating Scale (NRS) for pain, where 0 indicates no pain and 10 indicates the worst possible pain.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: